Home Zipongo Secures $18M Series B Funding to Advance Dietotherapy for Chronic Disease Prevention and Management

Zipongo Secures $18M Series B Funding to Advance Dietotherapy for Chronic Disease Prevention and Management

Nov 04, 2016 10:36 CST Updated 10:36

Digital nutrition platform Zipongo recently secured $18 million in Series B funding and will use the proceeds to further deepen its presence in the healthcare sector. The round was led by the prominent investment firm Mayfield, with continued participation from existing investors such as Excel Venture Management. Since raising $5 million in Series A funding in December 2014, Zipongo has spent the past two years transitioning toward helping individuals manage chronic diseases through customized meal plans, a strategy that has now gained market recognition.


In the realm of healthy eating, Zipongo is a standout company. Incubated by Rock Health and founded in 2010, the San Francisco-based startup has raised over $28 million to date. Zipongo operates a MealRx platform comprising various applications (available on both iOS and Android) designed to transform people’s dietary habits and nutritional status. What sets Zipongo apart is its ability to provide personalized recipes, shopping lists, and restaurant recommendations based on individual preferences. These recommendations are generated through intelligent algorithms that analyze collected personal health data.


QQ图片20161104102407_meitu_2.jpg

Zipongo's founding team is dedicated to uncovering the chronic disease prevention benefits of food therapy.


Zipongo founder Langheier pursued advanced studies at Duke University, Harvard University, and the University of California, San Francisco. He also established a pediatric weight management clinic at Boston Medical Center. Langheier’s philosophy is that if you want to be healthy, you must actively participate in your own health management and disease prevention programs.


Not only does it teach you meal planning, but it also lets you purchase discounted ingredients.


Most conventional meal-planning apps primarily teach you how to prepare delicious dishes, offering few personalized and precise recommendations. At Zipongo, after completing a personal information questionnaire, the platform leverages databases and algorithms to estimate each user’s cholesterol levels, blood pressure, height, weight, and body mass index (BMI). Based on individual health profiles, users can access recommended healthy meal plans, food tracking tools, calorie-restricted diets, weight-loss challenges, and detailed nutritional breakdowns for each dish (such as protein, calcium, vitamin content, and sugar levels), all presented through user-friendly visualized data. Zipongo aims to guide individuals toward healthier choices in their surroundings—including specific cafes or signature recipes from local restaurants—by fostering sustainable, long-term behavioral change.


Upon receiving a meal plan, Zipongo also addresses how to purchase the most affordable ingredients, which is its standout feature. For all items on the shopping list, Zipongo effectively leverages data from local supermarkets and stores to inform users which nearby supermarket offers the greatest discounts. CEO Jason Langheier has publicly stated, “This not only helps families save money, but food is the best medicine. We will continue to delve deeply into the field of food therapy, enabling more people to maintain healthy physical conditions through their daily diets, particularly in managing certain chronic diseases.”


Through the HIPAA-compliant data warehouse, users can connect to their electronic medical records and health data. This enables Zipongo to tailor wellness programs for users and provide relevant discount information. Users can purchase required food items by swiping a card or using a membership card. In this way, users, retailers, and healthcare service providers are all integrated into a single system.


For the Zipongo platform, it has also gone through different stages, with each stage having a different focus. The first stage was to build the most comprehensive nutrition platform, attracting diverse groups of people to converge on the platform. For example, some people enjoy cooking at home, others dine out regularly, and those with lower incomes may hope to purchase discounted ingredients. Through its matrix-style applications, Zipongo met the needs of these users and gained favor from employers as well as health plan organizations via an efficient recommendation mechanism.


Transforming Dietary Therapy to Improve Chronic Disease Prevention and Management


“After attracting traffic, Zipongo began the second phase of its transformation, entering the stage of chronic disease prevention for conditions such as obesity and diabetes, and even planning to use so-called ‘food as medicine’ approaches to address the prevention of other major diseases, including IBD and cancer,” Langheier explained regarding the transformation. “It is akin to pharmacy benefit management, except that we have essentially taken it to a new level. This is because the most powerful ‘generic drug’ is actually personalized food. Multiple RCTs (randomized controlled trials) have shown that, under many conditions, it is more cost-effective and has fewer side effects.” In fact, ever sinceFollowing the enactment of the ACA, demand for chronic disease management and disease control has grown increasingly strong. Currently, 150 companies and health organizations have partnered withCollaboration with Zipongo.


To provide more precise dietary recommendations for health, Zipongo needs to gain a deeper understanding of its users. By partnering with 23andMe, the company assesses users’ dietary preferences, health status, and disease risk from the perspectives of genetics, metabolomics, immune response, and the microbiome. However, to attract more suppliers and payers, the company must also demonstrate the efficacy of such dietary interventions, such as the Mediterranean diet.


“If dietary therapy is implemented effectively, its efficacy can actually rival that of pharmaceuticals!” explained Langheier. “To demonstrate its medical benefits, we must conduct research from the ground up. Through intelligent algorithms and collaborations with companies such as 23andMe, personalized nutrition has remained our steadfast focus.”